These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 22987264)

  • 1. [Evaluation of the variability in the susceptibility of Acinetobacter baumannii to tigecycline in the same medium with two methods of quantitative diffusion different commercial].
    Tejero R; Causse M; Moreno M; Solís F; Rodríguez-López F; Casal M
    Rev Esp Quimioter; 2012 Sep; 25(3):189-93. PubMed ID: 22987264
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Variability in the sensitivity to tigecycline against Acinetobacter baumannii in different culture media].
    Tenorio-Abreu A; Eiros JM; Rodríguez-Molins E; Andaluz D; Bobillo F; Domínguez-Gil M; Ortiz de Lejarazu R
    Rev Esp Quimioter; 2010 Jun; 23(2):76-80. PubMed ID: 20559605
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Comparison of disc diffusion, E-test, and broth microdilution methods for the determination of resistance to colistin, polymyxin B, and tigecycline in multi-resistant Acinetobacter baumannii isolates].
    Akin FE; Bayram A; Balci I
    Mikrobiyol Bul; 2010 Apr; 44(2):203-10. PubMed ID: 20549954
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of tigecycline susceptibility testing methods for multidrug-resistant Acinetobacter baumannii.
    Idelevich EA; Freeborn DA; Seifert H; Becker K
    Diagn Microbiol Infect Dis; 2018 Aug; 91(4):360-362. PubMed ID: 29778562
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of Minocycline Susceptibility Testing Methods for Carbapenem-Resistant Acinetobacter baumannii.
    Wang P; Bowler SL; Kantz SF; Mettus RT; Guo Y; McElheny CL; Doi Y
    J Clin Microbiol; 2016 Dec; 54(12):2937-2941. PubMed ID: 27629901
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In-vitro activity of tigecycline against clinical isolates of Acinetobacter baumannii in Taiwan.
    Liu JW; Wang LS; Cheng YJ; Hsu GJ; Lu PL; Liu YC; Chen CM; Lee CM; Sun W; Jang TN; Chiang PC; Chuang YC; Lin HC; Shi ZY; Kung HC; Huang CH; Tsao SM; Lu CT; Liao CH; Hsueh PR
    Int J Antimicrob Agents; 2008 Nov; 32 Suppl 3():S188-91. PubMed ID: 19013353
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Are E-test and Vitek2 good choices for tigecycline susceptibility testing when comparing broth microdilution for MDR and XDR Acinetobacter baumannii?
    Grandesso S; Sapino B; Amici G; Mazzucato S; Solinas M; Gion M
    New Microbiol; 2014 Oct; 37(4):503-8. PubMed ID: 25387287
    [TBL] [Abstract][Full Text] [Related]  

  • 8. High tigecycline resistance in multidrug-resistant Acinetobacter baumannii.
    Navon-Venezia S; Leavitt A; Carmeli Y
    J Antimicrob Chemother; 2007 Apr; 59(4):772-4. PubMed ID: 17353223
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparative assessment of antimicrobial susceptibility testing for tigecycline and colistin against Acinetobacter baumannii clinical isolates, including multidrug-resistant isolates.
    Piewngam P; Kiratisin P
    Int J Antimicrob Agents; 2014 Nov; 44(5):396-401. PubMed ID: 25442358
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In vitro activity of tigecycline against clinical isolates of multidrug-resistant Acinetobacter baumannii in Siriraj Hospital, Thailand.
    Tiengrim S; Tribuddharat C; Thamlikitkul V
    J Med Assoc Thai; 2006 Nov; 89 Suppl 5():S102-5. PubMed ID: 17718251
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In vitro Activity of Colistin in Combination with Tigecycline against Carbapenem-Resistant Acinetobacter baumannii Strains Isolated from Patients with Ventilator-Associated Pneumonia.
    Cikman A; Gulhan B; Aydin M; Ceylan MR; Parlak M; Karakecili F; Karagoz A
    Int J Med Sci; 2015; 12(9):695-700. PubMed ID: 26392806
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In-vitro activity of tigecycline against clinical isolates of Acinetobacter baumannii in Taiwan determined by the broth microdilution and disk diffusion methods.
    Liao CH; Kung HC; Hsu GJ; Lu PL; Liu YC; Chen CM; Lee CM; Sun W; Jang TN; Chiang PC; Cheng YJ; Lin HC; Shi ZY; Wang LS; Chuang YC; Tsao SM; Lu CT; Liu JW; Huang CH; Hsueh PR
    Int J Antimicrob Agents; 2008 Nov; 32 Suppl 3():S192-6. PubMed ID: 19013354
    [TBL] [Abstract][Full Text] [Related]  

  • 13. COMPARISON OF TWO DIFFERENT METHODS FOR TIGECYCLINE SUSCEPTIBILITY TESTING IN
    Bedenić B; Cavrić G; Vranić-Ladavac M; Barišić N; Karčić N; Tot T; Presečki-Stanko A; Lukić-Grlić A; Frančula-Zaninović S; Sreter KB
    Acta Clin Croat; 2018 Dec; 57(4):618-623. PubMed ID: 31168197
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacodynamics of tigecycline alone and in combination with colistin against clinical isolates of multidrug-resistant Acinetobacter baumannii in an in vitro pharmacodynamic model.
    Cai X; Yang Z; Dai J; Chen K; Zhang L; Ni W; Wei C; Cui J
    Int J Antimicrob Agents; 2017 May; 49(5):609-616. PubMed ID: 28315729
    [TBL] [Abstract][Full Text] [Related]  

  • 15. EVALUATION OF IN VITRO TIGECYCLINE ACTIVITY AGAINST MULTIDRUG-RESISTANT ACINETOBACTER BAUMANNII CLINICAL ISOLATES FROM POLAND.
    Paluchowska P; Nowak P; Skalkowska M; Bjdak A
    Acta Pol Pharm; 2017 May; 74(3):793-800. PubMed ID: 29513948
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comment on: High tigecycline resistance in multidrug-resistant Acinetobacter baumannii.
    Thamlikitkul V; Tiengrim S; Tribuddharat C
    J Antimicrob Chemother; 2007 Jul; 60(1):177-8; author reply 178-9. PubMed ID: 17496287
    [No Abstract]   [Full Text] [Related]  

  • 17. Reduced susceptibility of multidrug-resistant Acinetobacter baumannii to tigecycline in combination with 1-(1-naphthylmethyl)-piperazine is not a pH-dependent phenomenon.
    Wareham DW; Gordon NC; Casals JB; Bean DC
    J Antimicrob Chemother; 2009 May; 63(5):1075-6. PubMed ID: 19279048
    [No Abstract]   [Full Text] [Related]  

  • 18. Investigation of in-vitro susceptibility of multidrug-resistant Acinetobacter baumannii strains isolated from clinical specimens to tigecycline.
    Tas T; Kocoglu E; Mengeloglu Z; Bucak O; Karabörk S
    Bosn J Basic Med Sci; 2013 Nov; 13(4):266-70. PubMed ID: 24289764
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of the Etest and broth microdilution method for tigecycline susceptibility testing against clinical isolates of Acinetobacter baumannii from Taiwan.
    Liu JW; Jang TN; Cheng YJ; Hsu GJ; Sun W; Lu CT; Hsueh PR;
    Int J Antimicrob Agents; 2010 Feb; 35(2):201-2. PubMed ID: 19892530
    [No Abstract]   [Full Text] [Related]  

  • 20. In vitro activity of tigecycline against Acinetobacter baumannii isolates from a teaching hospital in Malaysia.
    Dhabaan GN; AbuBakar S; Shorman MA; Hassan H
    J Chemother; 2012 Apr; 24(2):87-92. PubMed ID: 22546763
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.